Viewing Study NCT00005967


Ignite Creation Date: 2025-12-25 @ 12:37 AM
Ignite Modification Date: 2026-02-26 @ 11:04 AM
Study NCT ID: NCT00005967
Status: COMPLETED
Last Update Posted: 2013-02-11
First Post: 2000-07-05
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Tipifarnib in Treating Patients With Advanced Hematologic Cancer
Sponsor: National Cancer Institute (NCI)
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Chronic Myeloproliferative Disorders View
None Leukemia View
None Lymphoma View
None Multiple Myeloma and Plasma Cell Neoplasm View
None Myelodysplastic Syndromes View
Keywords:

Keywords

Keyword Brief Keyword Text View
None stage III adult Hodgkin lymphoma View
None stage IV adult Hodgkin lymphoma View
None recurrent adult Hodgkin lymphoma View
None refractory multiple myeloma View
None stage III multiple myeloma View
None stage III chronic lymphocytic leukemia View
None stage IV chronic lymphocytic leukemia View
None recurrent adult acute myeloid leukemia View
None recurrent adult acute lymphoblastic leukemia View
None relapsing chronic myelogenous leukemia View
None refractory chronic lymphocytic leukemia View
None chronic phase chronic myelogenous leukemia View
None accelerated phase chronic myelogenous leukemia View
None blastic phase chronic myelogenous leukemia View
None refractory anemia with excess blasts View
None refractory anemia with excess blasts in transformation View
None chronic myelomonocytic leukemia View
None stage III grade 1 follicular lymphoma View
None stage III grade 2 follicular lymphoma View
None stage III grade 3 follicular lymphoma View
None stage III adult diffuse small cleaved cell lymphoma View
None stage III adult diffuse mixed cell lymphoma View
None stage III adult diffuse large cell lymphoma View
None stage III adult immunoblastic large cell lymphoma View
None stage III adult lymphoblastic lymphoma View
None stage III adult Burkitt lymphoma View
None stage IV grade 1 follicular lymphoma View
None stage IV grade 2 follicular lymphoma View
None stage IV grade 3 follicular lymphoma View
None stage IV adult diffuse small cleaved cell lymphoma View
None stage IV adult diffuse mixed cell lymphoma View
None stage IV adult diffuse large cell lymphoma View
None stage IV adult immunoblastic large cell lymphoma View
None stage IV adult lymphoblastic lymphoma View
None stage IV adult Burkitt lymphoma View
None recurrent grade 1 follicular lymphoma View
None recurrent grade 2 follicular lymphoma View
None recurrent grade 3 follicular lymphoma View
None recurrent adult diffuse small cleaved cell lymphoma View
None recurrent adult diffuse mixed cell lymphoma View
None recurrent adult diffuse large cell lymphoma View
None recurrent adult immunoblastic large cell lymphoma View
None recurrent adult lymphoblastic lymphoma View
None recurrent adult Burkitt lymphoma View
None previously treated myelodysplastic syndromes View
None secondary myelodysplastic syndromes View
None stage III mantle cell lymphoma View
None stage IV mantle cell lymphoma View
None recurrent mantle cell lymphoma View
None polycythemia vera View
None primary myelofibrosis View
None essential thrombocythemia View
None chronic eosinophilic leukemia View
None chronic neutrophilic leukemia View
None recurrent marginal zone lymphoma View
None recurrent small lymphocytic lymphoma View
None stage III small lymphocytic lymphoma View
None stage III marginal zone lymphoma View
None stage IV small lymphocytic lymphoma View
None stage IV marginal zone lymphoma View
None extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue View
None nodal marginal zone B-cell lymphoma View
None splenic marginal zone lymphoma View